# FDA Inspection 1008063 - Piotr Serwatowski - March 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/piotr-serwatowski/c89c80c7-bc8e-4009-a02f-245aafe34453
Source feed: FDA_Inspections

> FDA Inspection 1008063 for Piotr Serwatowski on March 10, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008063
- Company Name: Piotr Serwatowski
- Inspection Date: 2017-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/piotr-serwatowski/b58cae9b-3b64-40d1-b968-4050fc31953c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c